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The region of mitochondrial DNA corresponding to the intron mutant M6-200 in Saccharomyces cerevisiae 
D273-10B has been isolated, and the nucleotide sequence of a 519 bp RsaI fragment has been determined. 
Three nucleotide substitutions were found at nucleotides + 2650 (G -+T), + 2668 (G+A) and + 2798 
(A-G), all within the genetically defined location in the gene. Particular significance can beattributed 
to the first two changes (+ 2650 and + 2668), that can be genetically isolated from the third substitution 
and, in addition, alter conserved sequence features d tected in a study [(1982) Biochimie 64, 867-8811 of
fungal mitochondrial introns. 
Mtochondrial intron mutant DNA sequence 
1. INTRODUCTION 
The gene for mitochondrial apocytochrome b in 
Saccharomyces cerevisiae has a mosaic structure 
[l] and some of its introns contain open reading 
frames and harbor mutants that are tram-recessive 
and code for a maturase [2,3] that is necessary for 
the correct splicing of the message. The other class 
of introns usually contain no open reading frames 
and do not depend upon mitochondrial protein 
synthesis for its excision. Mutations that map in 
these introns are c&-dominant and are probably 
unable to provide the splicing enzymes with the 
correct RNA substrate [3,4]. To understand more 
fully the molecular basis of the c&-acting muta- 
tions we determined the nucleotide substitutions in 
M6-2OO/Al [5] a COB region mit- that maps in- 
side the last intron of the ‘short’ apocytochrome b 
gene [6] by sequencing the genetically defined 
region cloned and amplified in PB 347, a derived 
Q- mutant. A preliminary communication of this 
work has been presented [7]. 
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2. MATERIALS AND METHODS 
The PB347 clone used here was isolated from the 
mit- M6-2OO/Al (a, auxotrophic, Q+, LJ+, mit-) 
[8] by mutagenesis with ethidium bromide [9]. This 
Q- was genetically characterized by crosses with 
testers from the cytochrome b region [lo], oxi 
gene (a MlO-150/4D) [ll], tRNAASp gene (a 
M7-37/70 C) [12] and a COB region e-, derived 
from an isomitochondrial yeast strain that is able 
to restore respiratory competence in all cyto- 
chrome b mit- mutants utilized [lo]. Genetic pro- 
cedures used are described in [13]. 
Yeast mitochondria were purified from pro- 
toplasts as in [ 141. The mitochondria were lysed in 
buffered 2% sarkosyl, phenol extracted and the 
DNA purified on CsCl-ethidium bromide gra- 
dients [15]. 
Restriction endonucleases were obtained from 
Bethesda Research Laboratories, MD. RsaI was 
prepared as in [ 161. DNA restriction fragments 
were purified from 5% polyacrylamide gels, 
treated with bacterial alkaline phosphatase (Wor- 
thington Biochemicals, NY) and labeled at the 
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5 ’ -ends with bacteriophage T4 polynucleotide 
kinase (PL Biochemicals, WI) and [Y-~~P]ATP 
(> 3000 Ci/mmol). The labeled ATP was prepared 
under a FINEP contract at Dr J.C.C. Maia’s 
laboratory (IQUSP - Sao Paulo) as in [17] using 
carrier-free 32Pi obtained from CNEN-Sao Paulo. 
The procedures for manipulation and labeling of 
the DNA fragments, strand separation, elution of 
bands, chemical derivatization reactions and thin 
gel high-voltage sequencing follow the detailed 
protocols in [18]. 
3. RESULTS 
3.1. Characterization of PB 347 
This e- was selected among 104 clones derived 
from M6-200/Al after treatment with ethidium 
bromide. These clones were cytoplasmic petites 
that spanned the mitochondrial apocytochrome b 
(COB) region in S. cerevisiae D273-10B as shown 
by their failure to be restored to respiratory com- 
petence after crossing to a COB region e-, an oxi 
mit- tester (aMlO-150/4D) and a tRNAASp syn- 
tester (aM7-37/70C). Nevertheless these clones 
gave colonies able to grow in non-fermentable 
substrates after crossing to all mit- COB testers ex- 
cept M6-200 indicating that they carried this 
mitochondrial mutation. Twenty clones were 
picked at random, re-purified and tested for stabi- 
lity of marker retention. Mitochondrial DNA was 
purified from 9 of the most stable e- (>90%) and 
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Fig.1. Restriction digests of PB347 (lanes 1,3,5) and 
DS4OO/A12 (lanes 2,4,6) mitochondrial DNAs 
electrophoresed on a 0.9% agarose gel [lo]. (1,2) HinfI, 
(3,4) MboI, (5,6) RsaI. The size of DS4OO/A12 Mb01 
fragments (lane 4) is indicated in base pairs [6]. 
the complexity and size of the retained DNA seg- 
ment were analysed by restriction endonuclease 
cleavage and agarose gel electrophoresis. The 
chosen clone (PB 347) has a mitochondrial genome 
consisting of a circular DNA with a repeat unit 
length of 5.1 kbp and in fig.1 its restriction 
fragments are compared with the well character- 
ized DS400/A12 e- [lo]. The genetic and physical 
mapping of PB 347 located the unique sequence 
retained in this clone between 69.4 and 76.7 map 
units as shown in fig.2. 
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Fig.2. Restriction map and location of PB347 mitochondrial DNA relative to the COB region genetic markers. Bl, B2 
and B3: exon regions of the apocytochrome b gene. The approximate limits of the mitt mutations are indicated by the 
open boxes [6]. The arrows show the direction and approximate distances equenced from the restriction sites indicated. 
The interrupted line indicates the open reading frame in the first intron. Restriction sites: Mb01 (v), EcoRI (0), 
Hue111 (I), MncII (O), HinfI (I). RsaI (0). 
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Fig.3. Nucleotide substitutions in the M6-200 intron 
mutant. The figure shows autoradiographs of the 
5 ’ -end-labeled DNA fragments subjected to chemical 
degradation as in [ 181. The products have been resolved 
on 10% polyacrylamide gels, the location of the 
substitutions being indicated as in [6]; bb, location of the 
bromophenol blue marker dye. Sequence of the mutant 
519 bp RsaI fragment labeled at the HaeIII site: (A) 
Upstream sequence. The mutational alterations shown 
(C--+A and C--+T) correspond to a G-T 
transversion and a G-+A transition in the non- 
transcribed strand. (B) Downstream sequence. The 
mutation is an A--+G transition in the non-transcribed 
strand. Corresponding sequences of the wild-type 
mitochondrial DNA: (C) Upstream sequence from the 
labeled HpaIl site. The mitochondrial DNA was 
obtained from the e- DS400/A12 [6]. (D) Downstream 
sequence from the labeled Hue111 site. The 
mitochondrial DNA was purified from the e- 
DS4OO/M4 [6]. 
3.2. DNA sequencing of the mutant 
Previous work established the entire nucleotide 
sequence of 7.6 kbp of wild-type mitochondrial 
DNA retained in the petite clone DS4OO/A12 
derived from S. cerevisiae D273-10B. This unique 
sequence contains a glutamyl tRNA gene and the 
3 exons of the apocytochrome b gene (fig.2). It 
allowed a more precise mapping of the COB 
mutants [6,10,19], M6-200 being located in the last 
intron between positions + 2539 and + 2800 [6]. 
Analysis of restriction digests with the purpose of 
purifying the DNA fragments that spanned the 
above region failed to reveal the RsaI site that 
could be predicted by the published sequence [6] 
starting at nucleotide +2769. This prompted a 
revision of the sequence and it has been determined 
that there is indeed no RsaI site and the unique 
HaeIII site nearby is flanked by two HpaII sites 
[20]. To sequence the region where the M6-200 
mutation was previously [6] mapped the 519 bp 
RsaI fragment (nucleotide + 2446 to + 2964) from 
a digest of PB 347 mitochondrial DNA was elec- 
trophoretically purified in a 5% polyacrylamide 
gel. The eluted DNA was digested with HaeIII and 
the two resulting fragments (332 bp and 187 bp) 
were individually isolated, labeled and sequenced. 
The large fragment gels were readable up to 180 
nucleotides (both strands) and for the small frag- 
ment reading was sharp up to 160 nucleotides pro- 
viding ample overlap. Three nucleotide substitu- 
tions were found at nucleotides +2650 (G-T), 
+ 2668 (G-A) and + 2798 (A-G) as shown in 
fig.3. The substitutions at +2650 and + 2668 
(fig.3A) were also confirmed by sequencing the 
non-transcribed strand labeled at the RsaI site (not 
shown). 
4. DISCUSSION 
The mit- mutant M6-200 is located in the last in- 
tron of the short apocytochrome b gene [6]. It was 
induced with manganese and no revertants could 
be obtained [l 11. M6-200 lacks the characteristic 
apocytochrome b polypeptide on SDS-polyacryl- 
amide gels of mitochondrial translation products 
although a shorter polypeptide (-22 kDa) was 
detected [3,5]. The splicing defect present in 
M6-200 specifically blocks the removal of the last 
intron although it does not prevent the splicing of 
the first intron [4]. A phenotypic similar defect is 
caused by a nuclear mutation (cbp 2), and the cor- 
responding gene was recently cloned by comple- 
mentation [21]. The multiple substitutions found 
in M6-200 are consistent with the mutant stability 
and have been found by others [2] in some manga- 
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nese-induced mit - . It is unlikely that any of the 
mutations found was introduced by the ethidium 
bromide used to induce the e- clone of this mu- 
tant. Previous extensive sequencing of primary and 
secondary petite clones from the COB region did 
not reveal the concomitant appearance of point 
mutations [6]. The nucleotide substitutions found 
(fig.4) fall well inside the region covered by the 
complementing e- DS4OO/N31 [6]. One of them 
(A-G at +2798) can be abolished by recom- 
bination with Q- DS4OO/Mll that spans part of 
the second intron and the last exon (+2675 to 
+ 6125) of the apocytochrome b gene [6]. Never- 
theless DS4OO/Mll does not restore respiratory 
competence in M6-200 [6] pointing to a significant 
role for the other two substitutions in causing the 
mutant phenotype. It is worth mentioning that this 
mutation (+2798) modifies a 14 base sequence 
that has an inversely homologous counterpart 
located 98 nucleotides from the second exon (B2), 
introducing a mismatch in a possible secondary 
structure of the apocytochrome b transcript that 
could be important as a recognition site for the 
splicing enzymes as suggested in [6]. The next 
upstream substitution (G-A, + 2668) affects the 
G residue in the consensus equence TCANNGAC- 
TA found in [22] to be conserved among introns of 
fungi. This region is homologous to the R sequence 
element described in [23] and, as suggested by 
these authors, able to pair with the complementary 
S sequences located further downstream in mito- 
chondrial introns (fig.4B). The last substitution 
found (G-T, +2650) would abolish the G-C 
base pair that closes a conserved secondary struc- 
ture stem common to the apocytochrome b intron 
and the large 21 S rRNA intron of w+ strains [22] 
(fig.4A). The importance of the G residue at the 
consensus equence is suggested by its change to a 
T in mutants that map at the fourth intron of the 
long COB gene (box 9-M281) [24] and at the 
B 
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Fig.4. Schematic representation of the nucleotide sequence and secondary structure features of the transcript in the last 
intron of the ‘short’ COB gene indicating the changes found in M6-200. (A) Part of the secondary structure of the RNA 
transcribed from the last COB intron as proposed in [22) with the substitutions found in M6-200. Boxed stretches are 
common to most or all introns of group I [22]. The limits of the mitochondrial genomes of some Q- mutants relevant 
to this work (DS4OO/Mll, DS4OO/M4 and DS4OO/N31) have been marked. The continuous line indicates the 14 
nucleotide sequence that has an inverted repeat counterpart at the beginning of this intron. The intron spans 738 
nucleotides from position + 2225 to + 2962 [6,20]. (B) Possible pairing between sequence lements homologous to the 
R and S regions described in [23] and transcribed from the last COB intron. The arrow indicates the situation in M6-200. 
Nucleotide numbering follows 16,201. 
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homologous fourth intron of the oxi. mitochon- 
drial gene (G192) [25]. It is changed to an A in mu- 
tant V353 also at the box 9 locus in the long 
apocytochrome b gene [26]. These 3 mutants are 
single base substitutions and revert with a frequen- 
cy of 10e7 being located at the open reading frame 
in the corresponding introns. Authors in [27] sug- 
gested that the consensus equence is possibly in- 
volved in the splicing of the many introns where it 
was found: namely, mitochondrial genes of fungi 
[10,24,25,28-301 or plants [31] and also in nuclear 
rRNA introns present in T. thermophila [32,33] 
and P. polycephalum [34]. The role of the in- 
dividual mutations in M6-200 remains a question 
open to debate. The genetic data allow the exclu- 
sion of one mutation (+ 2798) alone as functional- 
ly nonessential to the maintenance of the changed 
phenotype in the presence of the other two ( + 2650 
and +2668) substitutions. The mutation at 
+ 2668, being located at a crucial G residue in the 
consensus equence [22-271, is probably sufficient 
to block intron processing by itself. The mutated 
sites mapped in M6-200, a c&acting mutant that 
does not contain an open reading frame, bring 
additional evidence to support the concept that 
sequence determinants located in introns are 
important in transcript processing. 
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